MARION's CARDIZEM SR COULD REPLACE ABOUT 50% OF CURRENT DILTIAZEM VOLUME WITHIN TWO YEARS OF APPROVAL: 120-DAY EXTENDED TERMS PLANNED FOR LAUNCH

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".